Envista Holdings Corp (STU:0HV)
€ 21 0 (0%) Market Cap: 3.63 Bil Enterprise Value: 4.18 Bil PE Ratio: 0 PB Ratio: 1.25 GF Score: 73/100

Envista Holdings Corp at JPMorgan Healthcare Conference Transcript

Jan 09, 2023 / 11:00PM GMT
Release Date Price: €30.41 (-1.46%)
Rachel Marie Vatnsdal Olson
JPMorgan Chase & Co, Research Division - Analyst

Perfect. Hi, everyone. This is Rachel Vatnsdal from the JPMorgan Tools and Diagnostics team. Today with me, I have Amir Aghdaei from the Envista team along with Howard. And so first, we're going to start off with a presentation with a presentation from management and then followed by Q&A. So during the Q&A session, you either can submit questions online through the portal. For those of you watching the webcast or if you're here in person, feel free to raise your hand. We do have mic runners with mics. So just make sure to raise your hands.

Amir Aghdaei
Envista Holdings Corporation - President, CEO & Director

Thank you so much. Thanks for having us in here. Good to be back again and happy new year to all of you. I wanted to give you a little bit of a perspective of Envista, we have been in public market for over 3 years now. We came out of Danaher as a spin-off. And I'll give you a little bit of a feel for the company itself, the performance and what we see happening

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot